21665--2/27/2009--COLGATE_PALMOLIVE_CO

related topics
{product, liability, claim}
{operation, international, foreign}
{cost, regulation, environmental}
{regulation, government, change}
{customer, product, revenue}
{regulation, change, law}
{product, candidate, development}
{system, service, information}
{operation, natural, condition}
{property, intellectual, protect}
{cost, operation, labor}
{condition, economic, financial}
{product, market, service}
changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenue we receive from non-U.S. markets or increase our labor or supply costs in those markets, exchange controls and other limits on our ability to repatriate earnings from overseas, which from time to time result in significant balances in countries such as Venezuela that are at risk for devaluation, political or economic instability or changing macroeconomic conditions in our major markets, lack of well-established or reliable legal systems in certain areas where the Company operates, foreign ownership restrictions and nationalization or expropriation of property or other resources, and foreign or domestic legal and regulatory requirements resulting in potentially adverse tax consequences or the imposition of onerous trade restrictions or other government controls. develop and fund technological innovations, receive and maintain necessary patent and trademark protection, obtain governmental approvals and registrations of regulated products, comply with U.S. Food and Drug Administration (FDA) and other governmental regulations, and anticipate consumer needs and preferences successfully. in the U.S., our products and the manufacture of our products are subject to regulation and review and/or approval by the Food and Drug Administration as well as by the Consumer Product Safety Commission and the Environmental Protection Agency; also in the U.S., claims and advertising with respect to our products are regulated by the Federal Trade Commission; we are also subject to regulation in the foreign countries in which we manufacture and sell our products and by state and local agencies in the U.S. that regulate in parallel to the above agencies; and our selling practices are regulated by competition authorities in the U.S. and abroad. availability of key raw materials, industrial accidents or other occupational health and safety issues, strikes and other labor disputes, loss or impairment of key manufacturing sites, raw material and product quality or safety issues, licensing requirements and other regulatory issues, and natural disasters, acts of war or terrorism and other external factors over which we have no control.

Full 10-K form ▸

related documents
892025--1/16/2007--MARTEK_BIOSCIENCES_CORP
892025--12/28/2007--MARTEK_BIOSCIENCES_CORP
874716--2/19/2010--IDEXX_LABORATORIES_INC_/DE
874716--2/20/2009--IDEXX_LABORATORIES_INC_/DE
10795--11/23/2007--BECTON_DICKINSON_&_CO
70793--11/30/2009--NBTY_INC
811669--2/23/2007--UST_INC
875045--3/3/2006--BIOGEN_IDEC_INC
10795--11/26/2008--BECTON_DICKINSON_&_CO
70793--11/27/2007--NBTY_INC
10795--11/30/2006--BECTON_DICKINSON_&_CO
70793--12/11/2006--NBTY_INC
1104280--12/3/2010--SANGUI_BIOTECH_INTERNATIONAL_INC
789868--4/2/2007--AMERICAN_DAIRY_INC
313143--5/25/2007--HAEMONETICS_CORP
874716--2/27/2008--IDEXX_LABORATORIES_INC_/DE
10795--11/24/2010--BECTON_DICKINSON_&_CO
1006195--6/8/2009--MATRIXX_INITIATIVES_INC
70793--12/1/2008--NBTY_INC
850693--3/1/2007--ALLERGAN_INC
850693--2/26/2010--ALLERGAN_INC
850693--3/6/2006--ALLERGAN_INC
10795--11/25/2009--BECTON_DICKINSON_&_CO
882873--9/20/2007--UROLOGIX_INC
1050007--11/29/2007--NUTRACEUTICAL_INTERNATIONAL_CORP
816284--2/18/2010--CELGENE_CORP_/DE/
884624--3/16/2007--ORTHOFIX_INTERNATIONAL_N_V
1030206--2/2/2010--VASCULAR_SOLUTIONS_INC
1030206--2/5/2008--VASCULAR_SOLUTIONS_INC
1030206--2/3/2009--VASCULAR_SOLUTIONS_INC